KOZARICH JOHN W — SEC Form 4 filings

SEC reporting owner CIK 1223000. 16 Form 4 filings on record with FilingPulse; latest filed 2026-06-09.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2024-04-26 to 2026-06-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
LIGAND PHARMACEUTICALS INC (LGND)Director1648 legs · 7,638 sh · $1,449,76214

Form 4 filings — KOZARICH JOHN W

FiledFormIssuerReported transactionsSource
2026-06-094LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 836 @ $0 · Grant/award (A): 2,938 (derivative) @ $0EDGAR
2026-05-144LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 80 @ $227.37 · Sale (S): 1 @ $229.87 · Sale (S): 165 @ $231.87 · Sale (S): 105 @ $232.57 · Sale (S): 116 @ $234.09 · Option exercise (M): 459 @ $69.51 · +5 moreEDGAR
2026-04-024LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 146 @ $199.97 · Sale (S): 40 @ $201.24 · Sale (S): 79 @ $202.42 · Sale (S): 43 @ $202.91 · Sale (S): 159 @ $204.26EDGAR
2026-03-044LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 47 @ $197.14 · Sale (S): 204 @ $199.69 · Sale (S): 41 @ $200.40 · Sale (S): 83 @ $201.65 · Sale (S): 50 @ $202.54 · Sale (S): 42 @ $203.57EDGAR
2026-02-044LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 39 @ $191 · Sale (S): 1 @ $192.18 · Sale (S): 23 @ $195.60 · Sale (S): 381 @ $196.36 · Sale (S): 23 @ $197.19EDGAR
2026-01-064LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 21 @ $186.59 · Sale (S): 91 @ $187.95 · Sale (S): 102 @ $188.96 · Sale (S): 207 @ $190.27 · Sale (S): 46 @ $192.40EDGAR
2025-12-034LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 92 @ $193.86 · Sale (S): 179 @ $194.76 · Sale (S): 47 @ $195.80 · Sale (S): 4 @ $196.34 · Sale (S): 92 @ $197.72 · Sale (S): 23 @ $199.22 · +1 moreEDGAR
2025-11-054LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 84 @ $189.00 · Sale (S): 49 @ $190.26 · Sale (S): 207 @ $191.25 · Sale (S): 127 @ $192.38EDGAR
2025-10-034LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 24 @ $177.60 · Sale (S): 196 @ $178.41 · Sale (S): 155 @ $180.01 · Sale (S): 92 @ $181.18EDGAR
2025-09-044LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 267 @ $161.51 · Sale (S): 115 @ $162.52 · Sale (S): 85 @ $164.25EDGAR
2025-08-054LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 467 @ $131.88EDGAR
2025-07-114LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 934 @ $125EDGAR
2025-06-104LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 1,209 @ $0 · Grant/award (A): 5,783 (derivative) @ $0EDGAR
2025-06-024LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 2,406 @ $52.30 · Option exercise (M): 2,406 (derivative) @ $0EDGAR
2024-06-184LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 1,252 @ $0 · Grant/award (A): 5,444 (derivative) @ $0EDGAR
2024-04-264LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 2,893 @ $39.35 · Option exercise (M): 2,893 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1223000 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →